Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice.
about
Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation studyPhotodynamic therapy for Staphylococcus aureus infected burn wounds in mice.Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acidSystem development for high frequency ultrasound-guided fluorescence quantification of skin layers.Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA.Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells.Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancerKinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated miceA comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma modelA monitor for Cellular Oxygen METabolism (COMET): monitoring tissue oxygenation at the mitochondrial level.5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives.Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro.White light-informed optical properties improve ultrasound-guided fluorescence tomography of photoactive protoporphyrin IX.Treatment of viral infections with 5-aminolevulinic acid and light.Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cellsTopical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.Derivatives of 5-aminolevulinic Acid for photodynamic therapy.Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.Small molecule additive enhances cell uptake of 5-aminolevulinic acid and conversion to protoporphyrin IX.Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy.In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research.
P2860
Q24803976-53A1F8DD-70D6-46E3-8522-0E4FDB177222Q33218150-EBA45DF9-64DE-4A21-BC1C-501CEABA6F78Q33585521-195EC2A2-4ED7-46E9-BCC9-3E148876E650Q33836259-9A90C8EF-D47B-4C48-AF1C-5F6DD7882A08Q34156019-053529FC-F5CD-4798-BF63-EA6DBC13DC83Q35097027-FC3AD07B-38FD-4AA0-89A6-F09C04438268Q36117103-1F0594C3-04D9-4F8E-AE8E-20D975229240Q36134283-A745601B-ABFC-4DE5-8706-3ABFBCDF55B9Q36138692-52C311A6-6DE9-4928-9E96-2CCA22FB6AF3Q36230000-D523538E-6D09-4452-A267-7EA7EC495C0CQ36423131-3C99F395-3823-49D2-BCE4-F844F6D709BDQ36620285-534E0CBD-9197-47A0-97A6-1106E7AEECF5Q36805234-0A0FD7A5-71B2-4C01-8603-71BA7F4A17A9Q36885820-AEF9A295-6566-4423-B417-99AA1C6B3054Q36936911-1340E875-1770-4150-A904-60823A90BAA8Q37355016-3A63B1D4-64B4-4C49-AE32-683C871D7B22Q37369850-2B296EB7-96BF-4A08-B302-1EF5B6BAD7E6Q42090164-3C135109-6073-4A94-AA35-15CAB6B96362Q42445389-9C542E8E-87C9-4FF4-BF4C-4D5B821BB12AQ42501688-7FF28A2E-CF91-455D-9E90-3E0BDECD9874Q42731042-6BF922ED-1949-4417-B8AD-26017261BDAFQ43287009-B964B494-E11F-440E-8923-E5ED42D77BB4Q43986459-5DD6AE52-0454-4462-8D5D-EE41102F1E18Q52617344-D1D80778-9C72-4A04-B252-34A4DA686CCFQ55054358-528C8897-9F5C-44E9-938F-CED23C37BF7E
P2860
Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Topical application of 5-amino ...... n in skin and tumours of mice.
@ast
Topical application of 5-amino ...... n in skin and tumours of mice.
@en
type
label
Topical application of 5-amino ...... n in skin and tumours of mice.
@ast
Topical application of 5-amino ...... n in skin and tumours of mice.
@en
prefLabel
Topical application of 5-amino ...... n in skin and tumours of mice.
@ast
Topical application of 5-amino ...... n in skin and tumours of mice.
@en
P2093
P1476
Topical application of 5-amino ...... n in skin and tumours of mice.
@en
P2093
A Orenstein
B Ehrenberg
G Kostenich
P304
P356
10.1016/1011-1344(95)07117-K
P577
1995-06-01T00:00:00Z